| Nutraceuticals-an emerging era in the treatment and prevention of cardiovascular diseases CS Ramaa, AR Shirode, AS Mundada, VJ Kadam Current pharmaceutical biotechnology 7 (1), 15-23, 2006 | 217 | 2006 |
| Thiazolidine-2, 4-diones: Progress towards multifarious applications VS Jain, DK Vora, CS Ramaa Bioorganic & medicinal chemistry 21 (7), 1599-1620, 2013 | 216 | 2013 |
| Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2, 4-thiazolidinedione derivatives V Patil, K Tilekar, S Mehendale-Munj, R Mohan, CS Ramaa European journal of medicinal chemistry 45 (10), 4539-4544, 2010 | 188 | 2010 |
| Thiazolidine-2, 4-diones derivatives as PPAR-γ agonists: Synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect … S Nazreen, MS Alam, H Hamid, MS Yar, A Dhulap, P Alam, MAQ Pasha, ... Bioorganic & medicinal chemistry letters 24 (14), 3034-3042, 2014 | 65 | 2014 |
| A new dawn for the use of thiazolidinediones in cancer therapy H Joshi, T Pal, CS Ramaa Expert opinion on investigational drugs 23 (4), 501-510, 2014 | 65 | 2014 |
| Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer K Tilekar, N Upadhyay, CV Iancu, V Pokrovsky, J Choe, CS Ramaa Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (2), 188457, 2020 | 61 | 2020 |
| 5-Benzylidene-2, 4-thiazolidenedione derivatives: design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2 U Bhanushali, S Rajendran, K Sarma, P Kulkarni, K Chatti, S Chatterjee, ... Bioorganic chemistry 67, 139-147, 2016 | 61 | 2016 |
| Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation N Upadhyay, K Tilekar, N Jänsch, M Schweipert, JD Hess, LH Macias, ... Bioorganic chemistry 100, 103934, 2020 | 45 | 2020 |
| Discovery of 5-naphthylidene-2, 4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines K Tilekar, N Upadhyay, N Jänsch, M Schweipert, P Mrowka, ... Bioorganic Chemistry 95, 103522, 2020 | 45 | 2020 |
| Design, synthesis, and biological evaluation of novel 2, 4-thiazolidinedione derivatives as histone deacetylase inhibitors targeting liver cancer cell line R Mohan, AK Sharma, S Gupta, CS Ramaa Medicinal Chemistry Research 21, 1156-1165, 2012 | 36 | 2012 |
| Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy N Upadhyay, K Tilekar, F Loiodice, NY Anisimova, TS Spirina, ... Bioorganic Chemistry 107, 104527, 2021 | 34 | 2021 |
| Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery K Tilekar, O Shelke, N Upadhyay, A Lavecchia, CS Ramaa Journal of Molecular Structure 1250, 131767, 2022 | 33 | 2022 |
| Spectrophotometric method for the estimation of Oxcarbazepine in tablets. C Ramaa, P Chothe, A Naik, V Kadam Indian journal of pharmaceutical sciences 68 (2), NA-NA, 2006 | 31 | 2006 |
| Permuted 2, 4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells K Tilekar, N Upadhyay, M Schweipert, JD Hess, LH Macias, P Mrowka, ... European Journal of Pharmaceutical Sciences 154, 105512, 2020 | 30 | 2020 |
| Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential K Tilekar, N Upadhyay, JD Hess, LH Macias, P Mrowka, RJ Aguilera, ... European journal of medicinal chemistry 202, 112603, 2020 | 29 | 2020 |
| Ester prodrugs of flurbiprofen: Synthesis, plasma hydrolysis and gastrointestinal toxicity R Mohan, CS Ramaa CSIR, 2007 | 22 | 2007 |
| Synthesis and evaluation of the hypoglycemic and hypolipidemic activity of novel 5-benzylidene-2, 4-thiazolidinedione analogs in a type-2 diabetes model S Mehendale-Munj, R Ghosh, CS Ramaa Medicinal Chemistry Research 20 (5), 642-647, 2011 | 21 | 2011 |
| Design and development of oxazol-5-ones as potential partial PPAR-γ agonist against cancer cell lines T Pal, H Joshi, CS Ramaa Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 14 (6), 872-883, 2014 | 18 | 2014 |
| Synthesis and anti-inflammatory activity of fluorinated propanedione derivatives AH More, CS Ramaa CSIR, 2010 | 17 | 2010 |
| Double-edged swords: diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis N Upadhyay, K Tilekar, S Safuan, AP Kumar, M Schweipert, ... Bioorganic Chemistry 116, 105350, 2021 | 16 | 2021 |
